# Zimmer Biomet to acquire A&E Medical for $250M

Zimmer Biomet announced the acquisition of A&E Medical, a provider of cardiothoracic surgical products including sternal closure devices, for $250 million in cash, with $150 million paid at closing and $100 million in 2021.

- Type: Acquisition
- Announced: 2020-12-01
- Where: United States
- Value: $250.0M
- Status: announced
- Products: cardiothoracic surgical products, sternal closure devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Vance Street Capital](https://endata.com/companies/9950.md) (investor)
- [Zimmer Biomet](https://endata.com/companies/30687.md) (acquirer)
- [A&E Medical](https://endata.com/companies/51571.md) (target)

## Sources

- [medtechdive.com](https://www.medtechdive.com/news/zimmer-acquires-ae-medical-boston-scientific-sells-btg-pharma-assets-serb/589885/), 2020-12-01: "Zimmer is paying $250 million in cash, staggered across this year and 2021, to buy A&E for a suite of sternal closure devices it sees as complementary to its current offerings."
- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/zimmer-biomet-ae-medical/), 2020-12-02: "Zimmer Biomet has acquired Vance Street Capital portfolio company A&E Medical, which manufactures sternal closure devices, for a total of $250m."
- [mddionline.com](https://www.mddionline.com/cardiovascular/medtech-in-a-minute-divestitures-and-m-a-oh-my-), 2020-12-07: "Zimmer Biomet has been quietly reving up its M&A engine in the past month, most recently with a deal to acquire A&E Medical for up to $250 million in cash."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.